ÂÜÀòÂÒÂ×

Albert Luderer is an accomplished executive with extensive experience in the biotechnology and diagnostics sectors, currently serving as Chairman of the Board at Bionano Genomics and Allergenis, and as CEO of Indi Molecular, Inc. since September 2013. Indi Molecular specializes in developing protein catalyzed capture agents intended to replace traditional antibody-based therapeutics. Luderer's previous leadership roles include CEO positions at Integrated Diagnostics and BioTrove, Inc., as well as CEO of Light Sciences Corporation. Luderer also held significant positions at bioMerieux, Inc., Dianon Systems, and Boehringer Mannheim, contributing to advancements in diagnostics and therapeutics. Luderer holds a PhD in Immunogenetics from Rutgers University and completed a postdoctoral fellowship in Immunochemistry and Immunogenetics at Thomas Jefferson University.